Search
Alobresib
go.drugbank.com/drugs/DB14970InvestigationalAlobresib is under investigation in clinical trial NCT02607228 (Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 as a Single Agent and In Combination With Enzalutamide in Participants
Rocapuldencel-T
go.drugbank.com/drugs/DB17588InvestigationalRocapuldencel-T is an autologous dendritic cell immunotherapy that was investigated in NCT02662634 (A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer
Synonyms: Rocapuldencel-TBenclonidine
go.drugbank.com/drugs/DB19610ExperimentalBenclonidine is a small molecule drug. The usage of the INN stem '-nidine' in the name indicates that Benclonidine is a a2 adrenoreceptor agonist. … Benclonidine has a monoisotopic molecular weight of 333.04 Da.
Modimelanotide
go.drugbank.com/drugs/DB15314InvestigationalModimelanotide is under investigation in clinical trial NCT01897519 (A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing
Amedalin
go.drugbank.com/drugs/DB09188ExperimentalAmedalin is a selective norepinephrine reuptake inhibitor developed in the 1970s. … It has no significant effect on reuptake of serotonin and dopamine and no antihistamine or anticholinergic properties. This drug was never marketed.
Flutonidine
go.drugbank.com/drugs/DB21438ExperimentalFlutonidine is a small molecule drug. The usage of the INN stem '-nidine' in the name indicates that Flutonidine is a a2 adrenoreceptor agonist. … Flutonidine has a monoisotopic molecular weight of 193.1 Da.
Povafonidine
go.drugbank.com/drugs/DB21470ExperimentalPovafonidine is a small molecule drug. The usage of the INN stem '-nidine' in the name indicates that Povafonidine is a a2 adrenoreceptor agonist. … Povafonidine has a monoisotopic molecular weight of 215.12 Da.
VIR201
go.drugbank.com/drugs/DB05110Experimentalis an experimental therapeutic vaccine currently in clinical trial. The aim of therapeutic vaccines is to augment the body's immune response to HIV and to delay or prevent progression to AIDS.
PS386113
go.drugbank.com/drugs/DB05211ExperimentalPS386113 is a small molecule drug candidate under investigation for the treatment of inflammatory disorders. It is being developed by Schering-Plough and Pharmacopeia.
(R)-Fluoxetine
go.drugbank.com/drugs/DB08472ExperimentalAn N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine that has R configuration (the antidepressant drug fluoxetine is a racemate comprising equimolar amounts of (R)- and (S)-fluoxetine).